Johnson & Johnson Consumer Inc. Consumer R&D community has been studying the microbiome for nearly a decade through both internal and external programs. We have uncovered significant advances in the infant and adult skin microbiome through our pioneering work. For the past 3 years, our focus has been on continuing to conduct fundamental research to better understand the healthy skin microbiome, while we concurrently look deeper into ways to correct microbiome imbalances present in a number of skin diseases.
Johnson & Johnson Consumer Inc. is committed to better understanding the role of the microbiome in skin health in a scientifically rigorous way in order to provide truly disruptive approaches to treating skin issues –particularly, inflammatory skin diseases. We are a leader in microbiome science and are working to translate its vast potential into therapies for patients and consumers around the world.